Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
Filed Aug 5, 2011 · 10-Q · 36 days after period end · 0001157523-11-004789
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $16.14M | $14.50M |
| Net Income | $2.28M | $1.07M |
| EPS Diluted | $0.17 | $0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 5, 2011 · 36 d after period end
